Increased pulse-wave velocity and carotid intima-media thickness in patients with lower urinary tract symptoms
Hakki Uzun1, Yüksel Çiçek, Sinan Altan Kocaman
1Departments of Urology, School of Medicine, Recep Tayyip Erdoğan University , Rize , Turkey.
Insights
Vascular impairment, including arterial stiffness and atherosclerosis, is significantly associated with lower urinary tract symptoms (LUTS) in men and overactive bladder (OAB) in women. These findings suggest a link between vascular health and urinary dysfunction.
Area of Science:
- Urology
- Cardiology
- Vascular Medicine
Background:
- Lower urinary tract symptoms (LUTS) in men and overactive bladder (OAB) in women often coexist with vascular risk factors.
- Atherosclerosis and endothelial dysfunction are implicated in LUTS development.
- Arterial stiffness, indicated by decreased arterial compliance, and carotid intima-media thickness (CIMT) are markers of vascular aging and impairment.
Purpose of the Study:
- To investigate the association between arterial stiffness and vascular atherosclerotic changes with LUTS in men and OAB in women.
- To explore the role of vascular health in the pathophysiology of lower urinary tract symptoms.
Main Methods:
- Prospective, cross-sectional study of 66 patients with LUTS/OAB and 62 controls.
- Carotid-femoral pulse-wave velocity (CF-PWV) measured as an index of arterial stiffness.
- Carotid intima-media thickness (CIMT) measured via B-mode ultrasonography to assess vascular impairment.
Main Results:
- Patients with LUTS/OAB exhibited significantly higher CF-PWV and CIMT compared to controls (p < 0.001 for both).
- Age and glucose levels were also significantly different between groups.
- Multivariate analyses confirmed that both CIMT and PWV were independently related to LUTS (p < 0.001).
Conclusions:
- Vascular impairment, including arterial stiffness and atherosclerosis, is significantly associated with LUTS in both men and women.
- Atherosclerosis-related vascular risk factors may share pathogenic pathways with LUTS.
- These findings highlight potential interactions between vascular health and urinary dysfunction.
Objective:
Vascular risk factors frequently coexist with lower urinary tract symptoms (LUTS) in both men and women, suggesting that atherosclerosis and endothelial dysfunction may play a major role in the development of LUTS. Arterial stiffness owing to decreased arterial compliance is one of the major signs of vascular ageing, and carotid intima-media thickness (CIMT) can be used in establishing the extent and severity of vascular impairment. This study investigated the association of arterial stiffness and vascular atherosclerotic involvement with LUTS in men and overactive bladder (OAB) in women.
Material And Methods:
This study was prospective and cross-sectional, consisting of 66 patients with LUTS (38 men with LUTS, 28 women with OAB) and 62 controls without LUTS or OAB. Carotid-femoral pulse-wave velocity (CF-PWV) was measured as an index of arterial stiffness. CIMT was measured with B-mode ultrasonography to assess vascular impairment.
Results:
Patients with LUTS had significantly higher CF-PWV (9.8 ± 2.6 vs 7.0 ± 1.4 m/s, p < 0.001) and CIMT (0.89 ± 0.16 and 0.56 ± 0.31 mm, p < 0.001) compared with controls. Age and glucose were also different between LUTS and control groups (p < 0.001 and p = 0.003, respectively). In the multivariate analyses, both CIMT ( = 0.429, p < 0.001) and PWV ( = 0.451, p < 0.001) were related to LUTS.
Conclusions:
Vascular impairment was found to be associated with LUTS in both men and women. Atherosclerosis-related vascular risk factors are also known to be related to LUTS and both disorders may have pathogenic interactions.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Urodynamic Studies: Uroflowmetry
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Hypertension III: Clinical Manifestations and Diagnostic Studies


